Skip to main content

What the FDA labels say about taking them together

Cyclosporine and foscarnet

Foscarnet's FDA label of December 11, 2025 names cyclosporine in its drug interactions section; the cyclosporine labels PlainMeds reads (4) do not name foscarnet.

Check it at the source: the cyclosporine FDA label on DailyMed (effective August 10, 2026, Novartis Pharmaceuticals Corporation); the foscarnet FDA label on DailyMed (effective December 11, 2025, Clinigen Limited).

What does the cyclosporine label say about foscarnet?

Cyclosporine's label (effective August 10, 2026) and its 3 other brand-application labels do not name foscarnet in these sections. A label lists what its studies and reports found; it is not a complete list.

Source: FDA drug label (Neoral), Novartis Pharmaceuticals Corporation, effective August 10, 2026 (SPL set 94461af3-11f1-4670-95d4-2965b9538ae3), via openFDA; the full label on DailyMed

What does the foscarnet label say about cyclosporine?

Foscarnet label, drug interactions

Because of foscarnet's tendency to cause renal impairment, the use of FOSCAVIR should be avoided in combination with potentially nephrotoxic drugs such as aminoglycosides, amphotericin B, cyclosporine, acyclovir, methotrexate, tacrolimus and intravenous pentamidine (see above) unless the potential benefits outweigh the risks to the patient.

Source: FDA drug label (Foscavir), Clinigen Limited, effective December 11, 2025 (SPL set 90e3da4e-3b1f-428b-99ca-e4bed1c80028), via openFDA; the full label on DailyMed

These are the labels' own sentences. PlainMeds does not grade interactions; a pharmacist or prescriber can say what they mean for one person's medicines.

Both medicines on the record

14Cyclosporine generic labelers
9Foscarnet generic labelers
CyclosporineFoscarnet
Labeled forOrgan transplant rejection, Rheumatoid arthritisn/a
Boxed warningYesYes
Pharmacy cost (NADAC)$1.04 per unit 0.05% eye emulsionn/a
Shortage nowNo current entryNo current entry

Source: FDA NDC Directory, CMS NADAC of October 7, 2026 and the FDA Drug Shortage Database (FDA files October 8, 2026)

What next?